Literature DB >> 2511088

Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease.

Y R Mahida1, K C Wu, D P Jewell.   

Abstract

Macrophages isolated from normal mucosa (greater than 5 cm from tumour) and inflamed mucosa (from patients with inflammatory bowel disease) of colon and ileum were studied for their ability to undergo a respiratory burst as assessed by reduction of nitroblue tetrazolium to formazan. Using phorbol myristate acetate (PMA) and opsonised zymosan as triggers, only a minority (median: 8% for zymosan and 9% for PMA) of macrophages isolated from normal colonic mucosa demonstrated release of oxygen radicals. In contrast, a significantly greater (median: 17% for zymosan and 45% for PMA) proportion of macrophages isolated from inflamed colonic mucosa were able to undergo respiratory burst. Studies with normal and inflamed ileum showed similar results. Stimulation of macrophages isolated from normal colon with interferon-gamma produced only a small increase in the proportion of cells showing release of oxygen radicals. We conclude that the respiratory burst capacity of majority of macrophages isolated from normal colon and ileum is downregulated and a greater proportion of macrophages isolated from inflamed colon and ileum are able to undergo a respiratory burst.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2511088      PMCID: PMC1434403          DOI: 10.1136/gut.30.10.1362

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  Phagocyte-generated oxygen metabolites and cellular injury.

Authors:  S J Weiss; A F LoBuglio
Journal:  Lab Invest       Date:  1982-07       Impact factor: 5.662

2.  Receptors for maleylated proteins regulate secretion of neutral proteases by murine macrophages.

Authors:  W J Johnson; S V Pizzo; M J Imber; D O Adams
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

Review 3.  The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages.

Authors:  E R Unanue
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

4.  Macrophage turnover in Crohn's disease and ulcerative colitis.

Authors:  G Meuret; A Bitzi; B Hammer
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

5.  Monocytes in inflammatory bowel disease: phagocytosis and intracellular killing.

Authors:  A S Mee; M Szawatakowski; D P Jewell
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

6.  Chronic inflammatory bowel disease--increased plasminogen activator secretion by mononuclear phagocytes.

Authors:  W F Doe; B Dorsman
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

7.  The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits.

Authors:  J C Mathison; R J Ulevitch
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

8.  In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes.

Authors:  H Carp; A Janoff
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

9.  Hydrogen peroxide metabolism in human monocytes during differentiation in vitro.

Authors:  A Nakagawara; C F Nathan; Z A Cohn
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

10.  Down-regulation of mannosyl receptor-mediated endocytosis and antigen F4/80 in bacillus Calmette-Guérin-activated mouse macrophages. Role of T lymphocytes and lymphokines.

Authors:  R A Ezekowitz; S Gordon
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  45 in total

1.  Phenotypic and functional characterisation of myofibroblasts, macrophages, and lymphocytes migrating out of the human gastric lamina propria following the loss of epithelial cells.

Authors:  K C Wu; L M Jackson; A M Galvin; T Gray; C J Hawkey; Y R Mahida
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

2.  Antigen induced suppression in peripheral blood and lamina propria mononuclear cells in inflammatory bowel disease.

Authors:  H R Dalton; P Hoang; D P Jewell
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

3.  Macrophage activity in inflammatory bowel disease.

Authors:  Y R Mahida; D P Jewell
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

4.  Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease.

Authors:  S J McKenzie; M S Baker; G D Buffinton; W F Doe
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 5.  Cigarette smoking and intestinal defences.

Authors:  G F Cope; R V Heatley
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

6.  Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease.

Authors:  M R Capobianchi; S Fais; F Mercuri; M Boirivant; F Dianzani; F Pallone
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

7.  Location of nitroblue tetrazolium-reducing activity in human colonic mucosa obtained by biopsy.

Authors:  N Oshitani; A Kitano; H Okabe; S Nakamura; T Matsumoto; K Kobayashi
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

8.  Location of superoxide anion generation in human colonic mucosa obtained by biopsy.

Authors:  N Oshitani; A Kitano; H Okabe; S Nakamura; T Matsumoto; K Kobayashi
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

9.  Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells.

Authors:  J Rugtveit; G Haraldsen; A K Høgåsen; A Bakka; P Brandtzaeg; H Scott
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

10.  5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease.

Authors:  Y R Mahida; C E Lamming; A Gallagher; A B Hawthorne; C J Hawkey
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.